Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc. (KPTI) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
kpti · stock forecast · 20 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 20 Wall Street analysts in the past 3 months
Buy
20 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$28.00
Consensus
$17.25
+102.9% upside
Low
$12.00
Median: $14.5 · Last Close: $8.50
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$17.25
102.9% upside
High Target
$28
229.4%
Low Target
$12
41.2%
Current Price
$8.50
as of today
Based on analyst price targets, the KPTI stock price prediction for the next 12 months ranges from $12 to $28. The consensus KPTI price forecast of $17.25 implies 102.9% upside from the current price of $8.50.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $8.71 | ↑ 2.52% |
1-day model range: $8.64–$8.79. Peak: $8.79 (+2.52%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $4 | -50.0% |
| 2028 | $3 | -62.5% |
| 2029 | $3 | -67.2% |
| 2030 | $3 | -69.2% |
| 2031 | — | -70.2% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · KPTI · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-06 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-04-27 | Piper Sandler | Maintains | Overweight→Overweight |
| 2026-03-30 | Piper Sandler | Maintains | Overweight→Overweight |
| 2026-03-25 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-25 | Baird | Maintains | Outperform→Outperform |
| 2026-02-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-04 | RBC Capital | Maintains | Outperform→Outperform |
| 2025-10-13 | HC Wainwright & Co. | Upgrade ↑ | Neutral→Buy |
| 2025-10-09 | Piper Sandler | Maintains | Overweight→Overweight |
| 2025-10-09 | Baird | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Karyopharm Therapeutics Inc. (KPTI) stock. Of the recent 129 rating actions, 9 were upgrades and 13 were downgrades. 20 analysts currently cover KPTI.
Analyst Recommendation Trends
KPTI analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$137M
↓ 40.4% YoY
Revenue Next Year
$155M
↑ 13.2% YoY
EPS This Year
$-4.08
EPS Next Year
$-3.12
↓ 23.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast KPTI EPS of $-4.08 for the current fiscal year, based on estimates from 3 analysts. The KPTI revenue forecast is $137M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The KPTI stock forecast is supported by two independent data sources: analyst consensus ratings from 20 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus KPTI price target is $17.25 (+102.9% upside), with an analyst consensus of Buy.
The KPTI short-term stock prediction for tomorrow is $8.71 (+2.52%). The KPTI stock price prediction for 2027 estimates an average of $4. The KPTI stock prediction for 2030 projects a range of $2–$3.
Karyopharm Therapeutics Inc. trades on NASDAQ under the ticker KPTI. The KPTI stock outlook for 2027 is broadly positive, supported by a Buy consensus among 70% of covering analysts.
Frequently asked questions
KPTI forecast · 8 questionsAccording to 20 Wall Street analysts, the average 12-month KPTI price target is $17.25, with a high forecast of $28.00 and a low of $12.00. The median price target is shown in the chart above when available. This implies +102.9% potential upside from the current price of $8.50.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.